{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:20:48Z","timestamp":1793319648486,"version":"4.5.0"},"reference-count":111,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-022-01432-8","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T09:02:41Z","timestamp":1665219761000},"page":"2205-2213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hypoxia-inducible factor signaling in vascular calcification in chronic kidney disease patients"],"prefix":"10.1093","volume":"35","author":[{"given":"Sidar","family":"Copur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Ucku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,8]]},"reference":[{"issue":"12","key":"1432_CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/jcm7120493","volume":"7","author":"W-C Lee","year":"2018","unstructured":"Lee W-C, Lee Y-T, Li L-C, Ng H-Y, Kuo W-H, Lin P-T et al (2018) The number of comorbidities predicts renal outcomes in patients with stage 3\u20135 chronic kidney disease. J Clin Med 7(12):493","journal-title":"J Clin Med"},{"issue":"4","key":"1432_CR2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.pop.2020.08.001","volume":"47","author":"C Charles","year":"2020","unstructured":"Charles C, Ferris AH (2020) Chronic kidney disease. Prim Care 47(4):585\u2013595","journal-title":"Prim Care"},{"key":"1432_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2018.08.046","volume":"278","author":"AB Reiss","year":"2018","unstructured":"Reiss AB, Miyawaki N, Moon J, Kasselman LJ, Voloshyna I, D\u2019Avino R Jr et al (2018) CKD, arterial calcification, atherosclerosis and bone health: inter-relationships and controversies. Atherosclerosis 278:49\u201359","journal-title":"Atherosclerosis"},{"issue":"6","key":"1432_CR4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s11255-016-1240-0","volume":"48","author":"AA Sag","year":"2016","unstructured":"Sag AA, Covic A, London G, Vervloet M, Goldsmith D, Gorriz JL et al (2016) Clinical imaging of vascular disease in chronic kidney disease. Int Urol Nephrol 48(6):827\u2013837","journal-title":"Int Urol Nephrol"},{"issue":"7","key":"1432_CR5","volume":"10","author":"S Liabeuf","year":"2015","unstructured":"Liabeuf S, Desjardins L, Diouf M, Temmar M, Renard C, Choukroun G et al (2015) The addition of vascular calcification scores to traditional risk factors improves cardiovascular risk assessment in patients with chronic kidney disease. PLoS\u00a0One 10(7):e0131707","journal-title":"PLoS\u00a0One"},{"issue":"5","key":"1432_CR6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1053\/j.ajkd.2011.07.020","volume":"58","author":"J Kendrick","year":"2011","unstructured":"Kendrick J, Chonchol M (2011) The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis 58(5):826\u2013834","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1432_CR7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J et al (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52(3):519\u2013530","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1432_CR8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000276665","volume":"29","author":"M Kanbay","year":"2010","unstructured":"Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A (2010) Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif 29(3):280\u2013292","journal-title":"Blood Purif"},{"issue":"2","key":"1432_CR9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000197562","volume":"27","author":"M Kanbay","year":"2009","unstructured":"Kanbay M, Goldsmith D, Akcay A, Covic A (2009) Phosphate\u2014the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif 27(2):220\u2013230","journal-title":"Blood Purif"},{"key":"1432_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/VHRM.S242685","volume":"16","author":"S Zununi Vahed","year":"2020","unstructured":"Zununi Vahed S, Mostafavi S, Hosseiniyan Khatibi SM, Shoja MM, Ardalan M (2020) Vascular calcification: an important understanding in nephrology. Vasc Health Risk Manag 16:167\u2013180","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"1432_CR11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ki.2010.326","volume":"79","author":"Z Wang","year":"2011","unstructured":"Wang Z, Tang L, Zhu Q, Yi F, Zhang F, Li PL et al (2011) Hypoxia-inducible factor-1\u03b1 contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int 79(3):300\u2013310","journal-title":"Kidney Int"},{"issue":"1","key":"1432_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/HYPERTENSIONAHA.115.05578","volume":"66","author":"R Luo","year":"2015","unstructured":"Luo R, Zhang W, Zhao C, Zhang Y, Wu H, Jin J et al (2015) Elevated endothelial hypoxia-inducible factor-1\u03b1 contributes to glomerular injury and promotes hypertensive chronic kidney disease. Hypertension 66(1):75\u201384","journal-title":"Hypertension"},{"issue":"4","key":"1432_CR13","doi-asserted-by":"crossref","first-page":"F1023","DOI":"10.1152\/ajprenal.90209.2008","volume":"295","author":"K Kimura","year":"2008","unstructured":"Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K, Harada K et al (2008) Stable expression of HIF-1\u03b1 in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 295(4):F1023\u2013F1029","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"1432_CR14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000449323","volume":"44","author":"N Kushida","year":"2016","unstructured":"Kushida N, Nomura S, Mimura I, Fujita T, Yamamoto S, Nangaku M et al (2016) Hypoxia-inducible factor-1\u03b1 activates the transforming growth factor-\u03b2\/SMAD3 pathway in kidney tubular epithelial cells. Am J Nephrol 44(4):276\u2013285","journal-title":"Am J Nephrol"},{"issue":"9","key":"1432_CR15","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1681\/ASN.2008070804","volume":"20","author":"L Gunaratnam","year":"2009","unstructured":"Gunaratnam L, Bonventre JV (2009) HIF in kidney disease and development. J Am Soc Nephrol 20(9):1877\u20131887","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1432_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1101\/gad.12.2.149","volume":"12","author":"NV Iyer","year":"1998","unstructured":"Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH et al (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1\u03b1. Genes Dev 12(2):149\u2013162","journal-title":"Genes Dev"},{"issue":"5","key":"1432_CR17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2004.09.026","volume":"6","author":"N Tang","year":"2004","unstructured":"Tang N, Wang L, Esko J, Giordano FJ, Huang Y, Gerber HP et al (2004) Loss of HIF-1\u03b1 in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6(5):485\u2013495","journal-title":"Cancer Cell"},{"issue":"11","key":"1432_CR18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tibs.2008.08.002","volume":"33","author":"M Yee Koh","year":"2008","unstructured":"Yee Koh M, Spivak-Kroizman TR, Powis G (2008) HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci 33(11):526\u2013534","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"1432_CR19","first-page":"205","volume":"7","author":"YZ Gu","year":"1998","unstructured":"Gu YZ, Moran SM, Hogenesch JB, Wartman L, Bradfield CA (1998) Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3\u03b1. Gene Expr 7(3):205\u2013213","journal-title":"Gene Expr"},{"issue":"2","key":"1432_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/geno.1998.5416","volume":"52","author":"NV Iyer","year":"1998","unstructured":"Iyer NV, Leung SW, Semenza GL (1998) The human hypoxia-inducible factor 1\u03b1 gene: HIF1A structure and evolutionary conservation. Genomics 52(2):159\u2013165","journal-title":"Genomics"},{"issue":"9","key":"1432_CR21","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.94.9.4273","volume":"94","author":"M Ema","year":"1997","unstructured":"Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1\u03b1 regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 94(9):4273\u20134278","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1432_CR22","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3390\/cells10092340","volume":"10","author":"MI Malkov","year":"2021","unstructured":"Malkov MI, Lee CT, Taylor CT (2021) Regulation of the Hypoxia-Inducible Factor (HIF) by pro-inflammatory cytokines. Cells 10(9):2340","journal-title":"Cells"},{"key":"1432_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.biochem.74.082803.133142","volume":"74","author":"WG Kaelin","year":"2005","unstructured":"Kaelin WG (2005) Proline hydroxylation and gene expression. Annu Rev Biochem 74:115\u2013128","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"1432_CR24","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2007-10-117812","volume":"111","author":"YA Minamishima","year":"2008","unstructured":"Minamishima YA, Moslehi J, Bardeesy N, Cullen D, Bronson RT, Kaelin WG Jr (2008) Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111(6):3236\u20133244","journal-title":"Blood"},{"issue":"5","key":"1432_CR25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrgastro.2010.39","volume":"7","author":"SP Colgan","year":"2010","unstructured":"Colgan SP, Taylor CT (2010) Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 7(5):281\u2013287","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6892","key":"1432_CR26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature00767","volume":"417","author":"WC Hon","year":"2002","unstructured":"Hon WC, Wilson MI, Harlos K, Claridge TD, Schofield CJ, Pugh CW et al (2002) Structural basis for the recognition of hydroxyproline in HIF-1\u03b1 by pVHL. Nature 417(6892):975\u2013978","journal-title":"Nature"},{"issue":"29","key":"1432_CR27","doi-asserted-by":"crossref","first-page":"26351","DOI":"10.1074\/jbc.C200273200","volume":"277","author":"KS Hewitson","year":"2002","unstructured":"Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW et al (2002) Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 277(29):26351\u201326355","journal-title":"J Biol Chem"},{"issue":"11","key":"1432_CR28","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-10-4142","volume":"71","author":"MY Koh","year":"2011","unstructured":"Koh MY, Lemos R Jr, Liu X, Powis G (2011) The hypoxia-associated factor switches cells from HIF-1\u03b1- to HIF-2\u03b1-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Res 71(11):4015\u20134027","journal-title":"Cancer Res"},{"issue":"9","key":"1432_CR29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tibs.2012.06.004","volume":"37","author":"MY Koh","year":"2012","unstructured":"Koh MY, Powis G (2012) Passing the baton: the HIF switch. Trends Biochem Sci 37(9):364\u2013372","journal-title":"Trends Biochem Sci"},{"issue":"24","key":"1432_CR30","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","volume":"23","author":"CJ Hu","year":"2003","unstructured":"Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC (2003) Differential roles of hypoxia-inducible factor 1\u03b1 (HIF-1alpha) and HIF-2\u03b1 in hypoxic gene regulation. Mol Cell Biol 23(24):9361\u20139374","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1432_CR31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/01.RES.0000134920.10128.b4","volume":"95","author":"N Takeda","year":"2004","unstructured":"Takeda N, Maemura K, Imai Y, Harada T, Kawanami D, Nojiri T et al (2004) Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1. Circ Res 95(2):146\u2013153","journal-title":"Circ Res"},{"issue":"4","key":"1432_CR32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","volume":"33","author":"GL Semenza","year":"2012","unstructured":"Semenza GL (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33(4):207\u2013214","journal-title":"Trends Pharmacol Sci"},{"issue":"14","key":"1432_CR33","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1093\/nar\/gkp425","volume":"37","author":"Y Benita","year":"2009","unstructured":"Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, Xavier RJ (2009) An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 37(14):4587\u20134602","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1432_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409238.2013.838205","volume":"49","author":"VL Dengler","year":"2014","unstructured":"Dengler VL, Galbraith M, Espinosa JM (2014) Transcriptional regulation by hypoxia inducible factors. Crit Rev Biochem Mol Biol 49(1):1\u201315","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"23","key":"1432_CR35","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/eurheartj\/ehu163","volume":"35","author":"P Lanzer","year":"2014","unstructured":"Lanzer P, Boehm M, Sorribas V, Thiriet M, Janzen J, Zeller T et al (2014) Medial vascular calcification revisited: review and perspectives. Eur Heart J 35(23):1515\u20131525","journal-title":"Eur Heart J"},{"key":"1432_CR36","doi-asserted-by":"crossref","unstructured":"Booth AL, Li CQ, Al-Dossari GA, Stevenson HL (2017) Abundant dystrophic calcifications mimicking aortic valve abscess in a patient undergoing elective aortic valve replacement. BMJ Case Rep 2017","DOI":"10.1136\/bcr-2017-220368"},{"issue":"11","key":"1432_CR37","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1161\/01.ATV.15.11.2003","volume":"15","author":"A Shioi","year":"1995","unstructured":"Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H (1995) Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15(11):2003\u20132009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"1432_CR38","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.mseb.2011.06.011","volume":"176","author":"D Lee","year":"2011","unstructured":"Lee D (2011) Vascular calcification: inducers and inhibitors. Mater Sci Eng B 176(15):1133\u20131141","journal-title":"Mater Sci Eng B"},{"issue":"35","key":"1432_CR39","doi-asserted-by":"crossref","first-page":"14170","DOI":"10.1073\/pnas.1208916109","volume":"109","author":"S Boonrungsiman","year":"2012","unstructured":"Boonrungsiman S, Gentleman E, Carzaniga R, Evans ND, McComb DW, Porter AE et al (2012) The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation. Proc Natl Acad Sci USA 109(35):14170\u201314175","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1432_CR40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nmat3627","volume":"12","author":"S Bertazzo","year":"2013","unstructured":"Bertazzo S, Gentleman E, Cloyd KL, Chester AH, Yacoub MH, Stevens MM (2013) Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat Mater 12(6):576\u2013583","journal-title":"Nat Mater"},{"issue":"6","key":"1432_CR41","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/ATVBAHA.119.312509","volume":"39","author":"E Balogh","year":"2019","unstructured":"Balogh E, T\u00f3th A, M\u00e9hes G, Trencs\u00e9nyi G, Paragh G, Jeney V (2019) Hypoxia triggers osteochondrogenic differentiation of vascular smooth muscle cells in an HIF-1 (hypoxia-inducible factor 1)-dependent and reactive oxygen species-dependent manner. Arterioscler Thromb Vasc Biol 39(6):1088\u20131099","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"1432_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046483","volume":"7","author":"M Wagegg","year":"2012","unstructured":"Wagegg M, Gaber T, Lohanatha FL, Hahne M, Strehl C, Fangradt M et al (2012) Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner. PLoS ONE 7(9):e46483","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"1432_CR43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0303-7207(02)00036-9","volume":"192","author":"J Park","year":"2002","unstructured":"Park J, Park B, Kim H, Park T, Baek H (2002) Hypoxia decreases Runx2\/Cbfa1 expression in human osteoblast-like cells. Mol Cell Endocrinol 192(1\u20132):197\u2013203","journal-title":"Mol Cell Endocrinol"},{"issue":"38","key":"1432_CR44","doi-asserted-by":"crossref","first-page":"40007","DOI":"10.1074\/jbc.M403715200","volume":"279","author":"A Salim","year":"2004","unstructured":"Salim A, Nacamuli RP, Morgan EF, Giaccia AJ, Longaker MT (2004) Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem 279(38):40007\u201340016","journal-title":"J Biol Chem"},{"issue":"3","key":"1432_CR45","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.kint.2016.05.020","volume":"90","author":"S Mokas","year":"2016","unstructured":"Mokas S, Larivi\u00e8re R, Lamalice L, Gobeil S, Cornfield DN, Agharazii M et al (2016) Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification. Kidney Int 90(3):598\u2013609","journal-title":"Kidney Int"},{"issue":"10","key":"1432_CR46","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201512-2380OC","volume":"194","author":"G Ruffenach","year":"2016","unstructured":"Ruffenach G, Chabot S, Tanguay VF, Courboulin A, Boucherat O, Potus F et al (2016) Role for runt-related transcription factor 2 in proliferative and calcified vascular lesions in pulmonary arterial hypertension. Am J Respir Crit Care Med 194(10):1273\u20131285","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1432_CR47","doi-asserted-by":"crossref","first-page":"13730","DOI":"10.1038\/s41598-018-31877-6","volume":"8","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Ma WQ, Han XQ, Wang Y, Wang X, Liu NF (2018) Advanced glycation end products accelerate calcification in VSMCs through HIF-1\u03b1\/PDK4 activation and suppress glucose metabolism. Sci Rep 8(1):13730","journal-title":"Sci Rep"},{"issue":"68","key":"1432_CR48","doi-asserted-by":"crossref","first-page":"112841","DOI":"10.18632\/oncotarget.22835","volume":"8","author":"WQ Ma","year":"2017","unstructured":"Ma WQ, Han XQ, Wang Y, Wang X, Zhu Y, Liu NF (2017) N\u03b5-carboxymethyl-lysine promotes calcium deposition in VSMCs via intracellular oxidative stress-induced PDK4 activation and alters glucose metabolism. Oncotarget 8(68):112841\u2013112854","journal-title":"Oncotarget"},{"key":"1432_CR49","doi-asserted-by":"crossref","first-page":"16577","DOI":"10.1038\/srep16577","volume":"5","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Jeong JY, Oh CJ, Park S, Kim JY, Kim HJ et al (2015) Pyruvate dehydrogenase kinase 4 promotes vascular calcification via SMAD1\/5\/8 phosphorylation. Sci Rep 5:16577","journal-title":"Sci Rep"},{"issue":"1","key":"1432_CR50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/cvr\/cvq152","volume":"88","author":"CM Lambert","year":"2010","unstructured":"Lambert CM, Roy M, Robitaille GA, Richard DE, Bonnet S (2010) HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism. Cardiovasc Res 88(1):196\u2013204","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1432_CR51","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2840-13-52","volume":"13","author":"G Li","year":"2014","unstructured":"Li G, Lu W, Ai R, Yang J, Chen F, Tang Z (2014) The relationship between serum hypoxia-inducible factor 1\u03b1 and coronary artery calcification in asymptomatic type 2 diabetic patients. Cardiovasc Diabetol 13(1):52","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"1432_CR52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/cyto.1999.0533","volume":"12","author":"G Hartmann","year":"2000","unstructured":"Hartmann G, Tsch\u00f6p M, Fischer R, Bidlingmaier C, Riepl R, Tsch\u00f6p K et al (2000) High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 12(3):246\u2013252","journal-title":"Cytokine"},{"issue":"16","key":"1432_CR53","first-page":"3915","volume":"59","author":"D Feldser","year":"1999","unstructured":"Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL (1999) Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 59(16):3915\u20133918","journal-title":"Cancer Res"},{"issue":"14","key":"1432_CR54","first-page":"2115","volume":"17","author":"YJ Jung","year":"2003","unstructured":"Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L (2003) IL-1beta-mediated up-regulation of HIF-1\u03b1 via an NF\u03baB\/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17(14):2115\u20132117","journal-title":"FASEB J"},{"issue":"6","key":"1432_CR55","doi-asserted-by":"crossref","first-page":"C1971","DOI":"10.1152\/ajpcell.2001.281.6.C1971","volume":"281","author":"JE Albina","year":"2001","unstructured":"Albina JE, Mastrofrancesco B, Vessella JA, Louis CA, Henry WL Jr, Reichner JS (2001) HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-\u03b1. Am J Physiol Cell Physiol 281(6):C1971\u2013C1977","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"1432_CR56","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.atherosclerosis.2007.05.026","volume":"195","author":"A Vink","year":"2007","unstructured":"Vink A, Schoneveld AH, Lamers D, Houben AJ, van der Groep P, van Diest PJ et al (2007) HIF-1\u03b1 expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. Atherosclerosis 195(2):e69-75","journal-title":"Atherosclerosis"},{"issue":"4","key":"1432_CR57","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jvs.2010.05.116","volume":"52","author":"A Bitto","year":"2010","unstructured":"Bitto A, De Caridi G, Polito F, Cal\u00f2 M, Irrera N, Altavilla D et al (2010) Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques. J Vasc Surg 52(4):1015\u20131021","journal-title":"J Vasc Surg"},{"issue":"1","key":"1432_CR58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/path.2518","volume":"218","author":"JC Sluimer","year":"2009","unstructured":"Sluimer JC, Daemen MJ (2009) Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 218(1):7\u201329","journal-title":"J Pathol"},{"issue":"10","key":"1432_CR59","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jclinpath-2012-200828","volume":"65","author":"L Gao","year":"2012","unstructured":"Gao L, Chen Q, Zhou X, Fan L (2012) The role of hypoxia-inducible factor 1 in atherosclerosis. J Clin Pathol 65(10):872\u2013876","journal-title":"J Clin Pathol"},{"issue":"1","key":"1432_CR60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jvs.2013.02.240","volume":"58","author":"CS Lim","year":"2013","unstructured":"Lim CS, Kiriakidis S, Sandison A, Paleolog EM, Davies AH (2013) Hypoxia-inducible factor pathway and diseases of the vascular wall. J Vasc Surg 58(1):219\u2013230","journal-title":"J Vasc Surg"},{"issue":"9","key":"1432_CR61","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1161\/ATVBAHA.116.307830","volume":"36","author":"A Aarup","year":"2016","unstructured":"Aarup A, Pedersen TX, Junker N, Christoffersen C, Bartels ED, Madsen M et al (2016) Hypoxia-inducible factor-1\u03b1 expression in macrophages promotes development of atherosclerosis. Arterioscler Thromb Vasc Biol 36(9):1782\u20131790","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"1432_CR62","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/HYPERTENSIONAHA.115.05886","volume":"66","author":"S Akhtar","year":"2015","unstructured":"Akhtar S, Hartmann P, Karshovska E, Rinderknecht FA, Subramanian P, Gremse F et al (2015) Endothelial hypoxia-inducible factor-1\u03b1 promotes atherosclerosis and monocyte recruitment by upregulating microRNA-19a. Hypertension 66(6):1220\u20131226","journal-title":"Hypertension"},{"issue":"3","key":"1432_CR63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00223-016-0206-7","volume":"100","author":"M Kanbay","year":"2017","unstructured":"Kanbay M, Vervloet M, Cozzolino M, Siriopol D, Covic A, Goldsmith D et al (2017) Novel faces of fibroblast growth factor 23 (FGF23): iron deficiency, inflammation, insulin resistance, left ventricular hypertrophy, proteinuria and acute kidney injury. Calcif Tissue Int 100(3):217\u2013228","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"1432_CR64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/apha.12096","volume":"208","author":"J Myllyharju","year":"2013","unstructured":"Myllyharju J (2013) Prolyl 4-hydroxylases, master regulators of the hypoxia response. Acta Physiol (Oxf) 208(2):148\u2013165","journal-title":"Acta Physiol (Oxf)"},{"issue":"23","key":"1432_CR65","doi-asserted-by":"crossref","first-page":"12969","DOI":"10.1073\/pnas.93.23.12969","volume":"93","author":"Z Arany","year":"1996","unstructured":"Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA et al (1996) An essential role for p300\/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 93(23):12969\u201312973","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1432_CR66","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cmet.2008.12.012","volume":"9","author":"YM Shah","year":"2009","unstructured":"Shah YM, Matsubara T, Ito S, Yim SH, Gonzalez FJ (2009) Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab 9(2):152\u2013164","journal-title":"Cell Metab"},{"issue":"7401","key":"1432_CR67","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature11055","volume":"486","author":"J Uniacke","year":"2012","unstructured":"Uniacke J, Holterman CE, Lachance G, Franovic A, Jacob MD, Fabian MR et al (2012) An oxygen-regulated switch in the protein synthesis machinery. Nature 486(7401):126\u2013129","journal-title":"Nature"},{"issue":"2","key":"1432_CR68","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00062752-199603020-00009","volume":"3","author":"GL Wang","year":"1996","unstructured":"Wang GL, Semenza GL (1996) Molecular basis of hypoxia-induced erythropoietin expression. Curr Opin Hematol 3(2):156\u2013162","journal-title":"Curr Opin Hematol"},{"issue":"12","key":"1432_CR69","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1182\/blood.V82.12.3610.3610","volume":"82","author":"GL Wang","year":"1993","unstructured":"Wang GL, Semenza GL (1993) Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82(12):3610\u20133615","journal-title":"Blood"},{"issue":"16","key":"1432_CR70","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1182\/blood-2010-02-270322","volume":"116","author":"PP Kapitsinou","year":"2010","unstructured":"Kapitsinou PP, Liu Q, Unger TL, Rha J, Davidoff O, Keith B et al (2010) Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116(16):3039\u20133048","journal-title":"Blood"},{"issue":"3","key":"1432_CR71","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/gast.2002.35353","volume":"123","author":"DM Frazer","year":"2002","unstructured":"Frazer DM, Wilkins SJ, Becker EM, Vulpe CD, McKie AT, Trinder D et al (2002) Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 123(3):835\u2013844","journal-title":"Gastroenterology"},{"issue":"10","key":"1432_CR72","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood-2002-04-1260","volume":"100","author":"DA Weinstein","year":"2002","unstructured":"Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC (2002) Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100(10):3776\u20133781","journal-title":"Blood"},{"issue":"9","key":"1432_CR73","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s11010-021-04168-4","volume":"476","author":"RE Afsar","year":"2021","unstructured":"Afsar RE, Kanbay M, Ibis A, Afsar B (2021) In-depth review: is hepcidin a marker for the heart and the kidney? Mol Cell Biochem 476(9):3365\u20133381","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"1432_CR74","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000328037","volume":"32","author":"MI Yilmaz","year":"2011","unstructured":"Yilmaz MI, Solak Y, Covic A, Goldsmith D, Kanbay M (2011) Renal anemia of inflammation: the name is self-explanatory. Blood Purif 32(3):220\u2013225","journal-title":"Blood Purif"},{"issue":"7","key":"1432_CR75","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI31370","volume":"117","author":"C Peyssonnaux","year":"2007","unstructured":"Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH et al (2007) Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Investig 117(7):1926\u20131932","journal-title":"J Clin Investig"},{"issue":"2","key":"1432_CR76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000446273","volume":"42","author":"Y Solak","year":"2016","unstructured":"Solak Y, Cetiner M, Siriopol D, Tarim K, Afsar B, Covic A et al (2016) Novel masters of erythropoiesis: hypoxia inducible factors and recent advances in anemia of renal disease. Blood Purif 42(2):160\u2013167","journal-title":"Blood Purif"},{"issue":"1","key":"1432_CR77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000452880","volume":"3","author":"X Lu","year":"2017","unstructured":"Lu X, Hu MC (2017) Klotho\/FGF23 axis in chronic kidney disease and cardiovascular disease. Kidney Dis (Basel) 3(1):15\u201323","journal-title":"Kidney Dis (Basel)"},{"issue":"2","key":"1432_CR78","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1530\/JME-20-0178","volume":"66","author":"BB Ho","year":"2021","unstructured":"Ho BB, Bergwitz C (2021) FGF23 signalling and physiology. J Mol Endocrinol 66(2):R23-r32","journal-title":"J Mol Endocrinol"},{"key":"1432_CR79","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000380970","volume":"185","author":"K Tsuchiya","year":"2015","unstructured":"Tsuchiya K, Nagano N, Nitta K (2015) Klotho\/FGF23 axis in CKD. Contrib Nephrol 185:56\u201365","journal-title":"Contrib Nephrol"},{"issue":"1","key":"1432_CR80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s40610-019-0110-9","volume":"5","author":"JA Wheeler","year":"2019","unstructured":"Wheeler JA, Clinkenbeard EL (2019) Regulation of fibroblast growth factor 23 by iron, EPO, and HIF. Curr Mol Biol Reports 5(1):8\u201317","journal-title":"Curr Mol Biol Reports"},{"issue":"4","key":"1432_CR81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MNH.0000000000000232","volume":"25","author":"C Francis","year":"2016","unstructured":"Francis C, David V (2016) Inflammation regulates fibroblast growth factor 23 production. Curr Opin Nephrol Hypertens 25(4):325\u2013332","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"1432_CR82","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/boneres.2016.11","volume":"4","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Doucet M, Tomlinson RE, Han X, Quarles LD, Collins MT et al (2016) The hypoxia-inducible factor-1\u03b1 activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia. Bone Res 4(1):16011","journal-title":"Bone Res"},{"issue":"5","key":"1432_CR83","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.2013.332","volume":"85","author":"R Jimbo","year":"2014","unstructured":"Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y et al (2014) Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney Int 85(5):1103\u20131111","journal-title":"Kidney Int"},{"issue":"18","key":"1432_CR84","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","volume":"125","author":"K Lim","year":"2012","unstructured":"Lim K, Lu T-S, Molostvov G, Lee C, Lam F, Zehnder D et al (2012) Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 125(18):2243\u20132255","journal-title":"Circulation"},{"key":"1432_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00207","author":"F Lang","year":"2018","unstructured":"Lang F, Leibrock C, Pelzl L, Gawaz M, Pieske B, Alesutan I et al (2018) Therapeutic interference with vascular calcification\u2014lessons from klotho-hypomorphic mice and beyond. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2018.00207","journal-title":"Front Endocrinol"},{"issue":"3","key":"1432_CR86","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.kint.2015.12.036","volume":"89","author":"MC Hu","year":"2016","unstructured":"Hu MC (2016) Klotho connects intermedin1\u201353 to suppression of vascular calcification in chronic kidney disease. Kidney Int 89(3):534\u2013537","journal-title":"Kidney Int"},{"issue":"1","key":"1432_CR87","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu MC, Shi M, Zhang J, Qui\u00f1ones H, Griffith C, Kuro-o M et al (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22(1):124\u2013136","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1432_CR88","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000509369","volume":"6","author":"X Bi","year":"2020","unstructured":"Bi X, Yang K, Zhang B, Zhao J (2020) The protective role of Klotho in CKD-associated cardiovascular disease. Kidney Dis 6(6):395\u2013406","journal-title":"Kidney Dis"},{"key":"1432_CR89","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","volume":"100","author":"S Yamada","year":"2017","unstructured":"Yamada S, Giachelli CM (2017) Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho. Bone 100:87\u201393","journal-title":"Bone"},{"issue":"1","key":"1432_CR90","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12964-018-0241-2","volume":"16","author":"Q Li","year":"2018","unstructured":"Li Q, Li Y, Liang L, Li J, Luo D, Liu Q et al (2018) Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK\/HIF1\u03b1 axis. Cell Commun Signal 16(1):26","journal-title":"Cell Commun Signal"},{"issue":"10","key":"1432_CR91","volume":"16","author":"A Urabe","year":"2021","unstructured":"Urabe A, Doi S, Nakashima A, Ike T, Morii K, Sasaki K et al (2021) Klotho deficiency intensifies hypoxia-induced expression of IFN-\u03b1\/\u03b2 through upregulation of RIG-I in kidneys. PLoS\u00a0One 16(10):e0258856","journal-title":"PLoS\u00a0One"},{"issue":"3","key":"1432_CR92","first-page":"15","volume":"20","author":"NK Yuen","year":"2016","unstructured":"Yuen NK, Ananthakrishnan S, Campbell MJ (2016) Hyperparathyroidism of renal disease. Permanente J 20(3):15\u2013127","journal-title":"Permanente J"},{"key":"1432_CR93","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bone.2015.07.002","volume":"81","author":"A Wong","year":"2015","unstructured":"Wong A, Loots GG, Yellowley CE, Dos\u00e9 AC, Genetos DC (2015) Parathyroid hormone regulation of hypoxia-inducible factor signaling in osteoblastic cells. Bone 81:97\u2013103","journal-title":"Bone"},{"issue":"1","key":"1432_CR94","doi-asserted-by":"crossref","first-page":"14005","DOI":"10.1038\/boneres.2014.5","volume":"2","author":"JL Frey","year":"2014","unstructured":"Frey JL, Stonko DP, Faugere M-C, Riddle RC (2014) Hypoxia-inducible factor-1\u03b1 restricts the anabolic actions of parathyroid hormone. Bone Research 2(1):14005","journal-title":"Bone Research"},{"issue":"35","key":"1432_CR95","doi-asserted-by":"crossref","first-page":"22554","DOI":"10.1074\/jbc.273.35.22554","volume":"273","author":"JM Dong","year":"1998","unstructured":"Dong JM, Leung T, Manser E, Lim L (1998) cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROK\u03b1. J Biol Chem 273(35):22554\u201322562","journal-title":"J Biol Chem"},{"issue":"11","key":"1432_CR96","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1359\/JBMR.040806","volume":"19","author":"JM Radeff","year":"2004","unstructured":"Radeff JM, Nagy Z, Stern PH (2004) Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C\u03b1 translocation and IL-6 promoter activity in osteoblastic cells. J Bone Miner Res 19(11):1882\u20131891","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1432_CR97","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bone.2009.03.675","volume":"45","author":"NH Kazmers","year":"2009","unstructured":"Kazmers NH, Ma SA, Yoshida T, Stern PH (2009) Rho GTPase signaling and PTH 3\u201334, but not PTH 1\u201334, maintain the actin cytoskeleton and antagonize bisphosphonate effects in mouse osteoblastic MC3T3-E1 cells. Bone 45(1):52\u201360","journal-title":"Bone"},{"issue":"3","key":"1432_CR98","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1160\/TH09-12-0814","volume":"104","author":"WL Lau","year":"2010","unstructured":"Lau WL, Festing MH, Giachelli CM (2010) Phosphate and vascular calcification: emerging role of the sodium-dependent phosphate co-transporter PiT-1. Thromb Haemost 104(3):464\u2013470","journal-title":"Thromb Haemost"},{"issue":"4","key":"1432_CR99","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/toxins11040213","volume":"11","author":"M Cozzolino","year":"2019","unstructured":"Cozzolino M, Ciceri P, Galassi A, Mangano M, Carugo S, Capelli I et al (2019) The key role of phosphate on vascular calcification. Toxins 11(4):213","journal-title":"Toxins"},{"issue":"21","key":"1432_CR100","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1001\/archinte.167.21.2368-a","volume":"167","author":"V Savica","year":"2007","unstructured":"Savica V, Bellinghieri G, Santoro D (2007) Phosphorus-related mechanisms of vascular calcification. Arch Internal Med 167(21):2368","journal-title":"Arch Internal Med"},{"issue":"8","key":"1432_CR101","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1476-5381.2008.00108.x","volume":"156","author":"K Terai","year":"2009","unstructured":"Terai K, Nara H, Takakura K, Mizukami K, Sanagi M, Fukushima S et al (2009) Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels. Br J Pharmacol 156(8):1267\u20131278","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1432_CR102","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","volume":"109","author":"CM Shanahan","year":"2011","unstructured":"Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM (2011) Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109(6):697\u2013711","journal-title":"Circ Res"},{"issue":"7","key":"1432_CR103","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2008070692","volume":"20","author":"M Mizobuchi","year":"2009","unstructured":"Mizobuchi M, Towler D, Slatopolsky E (2009) Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 20(7):1453\u20131464","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1432_CR104","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/MCB.22.6.1734-1741.2002","volume":"22","author":"K Salnikow","year":"2002","unstructured":"Salnikow K, Kluz T, Costa M, Piquemal D, Demidenko ZN, Xie K et al (2002) The regulation of hypoxic genes by calcium involves c-Jun\/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol Cell Biol 22(6):1734\u20131741","journal-title":"Mol Cell Biol"},{"issue":"43","key":"1432_CR105","doi-asserted-by":"crossref","first-page":"44976","DOI":"10.1074\/jbc.M313995200","volume":"279","author":"U Berchner-Pfannschmidt","year":"2004","unstructured":"Berchner-Pfannschmidt U, Petrat F, Doege K, Trinidad B, Freitag P, Metzen E et al (2004) Chelation of cellular calcium modulates hypoxia-inducible gene expression through activation of hypoxia-inducible factor-1\u03b1. J Biol Chem 279(43):44976\u201344986","journal-title":"J Biol Chem"},{"key":"1432_CR106","doi-asserted-by":"crossref","unstructured":"Neradova A, Wasilewski G, Prisco S, Leenders P, Caron M, Welting T et al (2021) Combining phosphate binder therapy with vitamin K2 inhibits vascular calcification in an experimental animal model of kidney failure. Nephrol Dial Transplant.\u00a02022 Mar 25;37(4):652\u2013662","DOI":"10.1093\/ndt\/gfab314"},{"issue":"9","key":"1432_CR107","doi-asserted-by":"crossref","first-page":"631","DOI":"10.20452\/pamw.3041","volume":"125","author":"I Kurnatowska","year":"2015","unstructured":"Kurnatowska I, Grzelak P, Masajtis-Zagajewska A, Kaczmarska M, Stefa\u0144czyk L, Vermeer C et al (2015) Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3\u20135. Pol Arch Med Wewn 125(9):631\u2013640","journal-title":"Pol Arch Med Wewn"},{"key":"1432_CR108","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3389\/fphys.2019.01584","volume":"10","author":"A Nagy","year":"2019","unstructured":"Nagy A, Peth\u0151 D, G\u00e1ll T, Zavaczki E, Nyitrai M, Posta J et al (2019) Zinc inhibits HIF-prolyl hydroxylase inhibitor-aggravated VSMC calcification induced by high phosphate. Front Physiol 10:1584","journal-title":"Front Physiol"},{"issue":"1","key":"1432_CR109","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1038\/s41598-019-51343-1","volume":"9","author":"R Bessho","year":"2019","unstructured":"Bessho R, Takiyama Y, Takiyama T, Kitsunai H, Takeda Y, Sakagami H et al (2019) Hypoxia-inducible factor-1\u03b1 is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy. Sci Rep 9(1):14754","journal-title":"Sci Rep"},{"issue":"3","key":"1432_CR110","first-page":"F227","volume":"309","author":"J O'Neill","year":"2015","unstructured":"O\u2019Neill J, Fasching A, Pihl L, Patinha D, Franz\u00e9n S, Palm F (2015) Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats. Am J Physiol 309(3):F227\u2013F234","journal-title":"Am J Physiol"},{"issue":"5","key":"1432_CR111","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/dom.13961","volume":"22","author":"M Packer","year":"2020","unstructured":"Packer M (2020) Interplay of adenosine monophosphate-activated protein kinase\/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: a novel conceptual framework. Diabetes Obes Metab 22(5):734\u2013742","journal-title":"Diabetes Obes Metab"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-022-01432-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:24Z","timestamp":1777564464000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/35\/9\/2205\/8325604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":111,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1007\/s40620-022-01432-8","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,8]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}